Literature DB >> 25870916

Clinical and pathological characterization of endometrial cancer in young women: identification of a cohort without classical risk factors.

Angela Burleigh1, Aline Talhouk2, C Blake Gilks2, Jessica N McAlpine3.   

Abstract

OBJECTIVE: Endometrial cancer (EC) is the most common gynecologic malignancy with known risk factors including excess estrogen and hereditary syndromes. The objective of this study was to determine the proportion of young women with EC that could be attributed to these factors and if, as we suspected, there is a third population of young women in which neither factor is identifiable. We were interested in comparing clinicopathologic characteristics and outcomes across subgroups in order to better inform treatment recommendations.
METHODS: We performed a retrospective chart review of women age 15-49 diagnosed with EC or complex atypical hyperplasia. Demographic, clinicopathologic, treatment, fertility, and outcome parameters were analyzed.
RESULTS: Of 719 women identified, 327 were fully evaluable. 57.5% fit the "High Estrogen" risk criteria. 8.25% met criteria for suspected Lynch syndrome. 34.25% classified as "Neither" had no classical risk factors identified. There were no statistical differences in age, gravidity, tumor grade, treatment selection and response to hormonal therapy. Age of menarche, stage, histology, and synchronous ovarian cancer differed significantly. Prevalence of synchronous ovarian cancer was 21.0% of "Neither", 23.1% of "Lynch", and 6.6% of "High Estrogen". For women who attempted pregnancy, 2/27 of "High Estrogen", 0/3 of "Lynch", and 2/16 of "Neither" achieved a live birth.
CONCLUSIONS: This study confirmed that a third population of young women with EC exist that lack classical risk factors and have distinct clinicopathologic parameters. No difference in success of conservative treatment or live births was noted in the small cohort in whom this treatment approach was attempted.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometrial cancer; Lynch syndrome; Obesity; Outcomes; Young women

Mesh:

Substances:

Year:  2015        PMID: 25870916     DOI: 10.1016/j.ygyno.2015.02.028

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Endometrial Cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review.

Authors:  Hongfa Peng; Jingjing Jiang; Xiaodong Li
Journal:  Reprod Sci       Date:  2022-05-31       Impact factor: 2.924

2.  A clinically applicable molecular-based classification for endometrial cancers.

Authors:  A Talhouk; M K McConechy; S Leung; H H Li-Chang; J S Kwon; N Melnyk; W Yang; J Senz; N Boyd; A N Karnezis; D G Huntsman; C B Gilks; J N McAlpine
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

3.  Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.

Authors:  Xiaopei Chao; Lei Li; Ming Wu; Shuiqing Ma; Xianjie Tan; Sen Zhong; Yalan Bi; Jinghe Lang
Journal:  Cancer Commun (Lond)       Date:  2019-07-15

Review 4.  The Perspectives of Fertility Preservation in Women with Endometrial Cancer.

Authors:  Jure Knez; Leyla Al Mahdawi; Iztok Takač; Monika Sobočan
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

5.  Endometrial Cancer in Pre-Menopausal Women and Younger: Risk Factors and Outcome.

Authors:  Nurliza Abdol Manap; Beng Kwang Ng; Su Ee Phon; Abdul Kadir Abdul Karim; Pei Shan Lim; Maimunah Fadhil
Journal:  Int J Environ Res Public Health       Date:  2022-07-25       Impact factor: 4.614

6.  Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer.

Authors:  Muhammad Sasmito Djati; Muhaimin Rifa'i
Journal:  Ann Med Surg (Lond)       Date:  2016-02-26

7.  The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.

Authors:  Xiangbo Zhan; Lei Li; Ming Wu; Jinghe Lang
Journal:  Arch Gynecol Obstet       Date:  2019-09-14       Impact factor: 2.344

8.  Peritumoral Enhancement for the Evaluation of Myometrial Invasion in Low-Risk Endometrial Carcinoma on Dynamic Contrast-Enhanced MRI.

Authors:  Tingting Cui; Feng Shi; Bei Gu; Yanfang Jin; Jinsong Guo; Chao Zhang; Jie Ren; Yunlong Yue
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.